Gregory Ginger bought BIIB

February 7, 2025 · Form 4 insider transaction

Gregory Ginger bought 1,635 shares of Biogen Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.

Direction

Acquired (buy-side)

1,635

Price

$0.00

Total value

N/A

InsiderGregory Ginger

Role—

CompanyBiogen Inc. (BIIB)

SecurityCommon Stock

Transaction codeM — Option exercise

Transaction dateFebruary 7, 2025

Filing dateFebruary 10, 2025

Shares owned after15,312

OwnershipDirect

10b5-1 planNo

AmendedNo

Footnotes

Includes 93.3846 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2024.

View the original Form 4 on SEC EDGAR